Drug Database
J05 ANTIVIRALS FOR SYSTEMIC USE
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- J05AB01 aciclovir
- J05AB03 vidarabine
- J05AB06 ganciclovir
- J05AB09 famciclovir
- J05AB11 valaciclovir
- J05AB12 cidofovir
- J05AB14 valganciclovir
- J05AB16 remdesivir
- J05AB18 molnupiravir
- J05AD01 foscarnet
- J05AE03 ritonavir
- J05AE07 fosamprenavir
- J05AE08 atazanavir
- J05AE10 darunavir
- J05AE30 nirmatrelvir and ritonavir
- J05AF01 zidovudine
- J05AF05 lamivudine
- J05AF06 abacavir
- J05AF07 tenofovir disoproxil
- J05AF09 emtricitabine
- J05AF10 entecavir
- J05AF11 telbivudine
- J05AF13 tenofovir alafenamide
- J05AG01 nevirapine
- J05AG03 efavirenz
- J05AG04 etravirine
- J05AG05 rilpivirine
- J05AG06 doravirine
- J05AH01 zanamivir
- J05AH02 oseltamivir
- J05AJ01 raltegravir
- J05AJ03 dolutegravir
- J05AJ04 cabotegravir
- J05AP01 ribavirin
- J05AP08 sofosbuvir
- J05AP51 sofosbuvir and ledipasvir
- J05AP54 elbasvir and grazoprevir
- J05AP55 sofosbuvir and velpatasvir
- J05AP56 sofosbuvir, velpatasvir and voxilaprevir
- J05AP57 glecaprevir and pibrentasvir
- J05AR01 zidovudine and lamivudine
- J05AR02 lamivudine and abacavir
- J05AR03 tenofovir disoproxil and emtricitabine
- J05AR04 zidovudine, lamivudine and abacavir
- J05AR06 emtricitabine, tenofovir disoproxil and efavirenz
- J05AR08 emtricitabine, tenofovir disoproxil and rilpivirine
- J05AR09 emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
- J05AR10 lopinavir and ritonavir
- J05AR12 lamivudine and tenofovir disoproxil
- J05AR13 lamivudine, abacavir and dolutegravir
- J05AR14 darunavir and cobicistat
- J05AR15 atazanavir and cobicistat
- J05AR17 emtricitabine and tenofovir alafenamide
- J05AR18 emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
- J05AR19 emtricitabine, tenofovir alafenamide and rilpivirine
- J05AR20 emtricitabine, tenofovir alafenamide and bictegravir
- J05AR21 dolutegravir and rilpivirine
- J05AR22 emtricitabine, tenofovir alafenamide, darunavir and cobicistat
- J05AR24 lamivudine, tenofovir disoproxil and doravirine
- J05AR25 lamivudine and dolutegravir
- J05AX05 inosine pranobex
- J05AX07 enfuvirtide
- J05AX09 maraviroc
- J05AX10 maribavir
- J05AX18 letermovir
- J05AX23 ibalizumab
- J05AX25 baloxavir marboxil
- J05AX28 bulevirtide
- J05AX29 fostemsavir
- J05AX31 lenacapavir
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).